About us

Solution provider to eliminate the global bottle neck in the development of nucleic acid therapeutics

AccuRna is pioneering unique drug delivery system (DDS) for nucleic acid therapeutics, both of short chain including ASO, siRNA, miRNA and long chain, mRNA as a therapeutic drug. Our aim is to promote therapeutic innovation in the form of nucleic acid medicine utilizing our robust DDS platform, providing effective treatment for refractory diseases for which there is currently no cure.

AccuRna was founded in 2015 to implement research results in academia socially.

Our dream is to deliver a “radical cure” to patients suffering from refractory diseases all over the world by safely and efficiently achieving the ultimate in the therapy utilizing nucleic acid.


Download the AccuRna's Corporate Overview